Moomoo Concludes Second Global Paper Trading Competition; Hong Kong SAR and Singapore Traders Top Leaderboard with Record Returns
JERSEY CITY, N.J., Dec. 18, 2025 /PRNewswire/ -- Moomoo, a leading global investment and trading platform, announced the successful conclusion of its Second Global Paper Trading Competition ("The Competition"). The six-week competition, powered by...
Korea Town Announces Expansion and New Vision as the Leading K-Beauty Destination in the Middle East
KUWAIT CITY, Kuwait, Dec. 18, 2025 /PRNewswire/ -- Korea Town, a K-beauty retail concept owned and powered by Boutiqaat, the Middle East's largest K-beauty destination, announces a renewed vision to become the most trusted global destination for...
FXTRADING.com Names Patrick Guerrera as Chief Brand Officer to Strengthen Global Positioning
SYDNEY, Dec. 18, 2025 /PRNewswire/ -- FXTRADING.com has appointed Patrick Guerrera as its new Chief Brand Officer, further strengthening its leadership team following a series of recent senior appointments as the company accelerates its global...
DREAME Unveils "Whole-Home Smart Living" Strategy in Vietnam, Advancing Toward a Next-Generation Home Infrastructure Brand
Evolving from a cleaning-tech champion into a full-home lifestyle brand, DREAME begins with core categories like refrigeration and laundry, using flagship innovation and a structured product portfolio to reshape how Vietnamese families live at home...
Cross-Border Email Becomes an Operational Imperative: How Coremail Helps Hong Kong Enterprises Navigate Global Communication Challenges
HONG KONG, Dec. 18, 2025 /PRNewswire/ -- For Hong Kong enterprises acting as the bridge between Mainland China and the global market, email reliability is no longer just an IT metric, it is the lifeline of day-to-day operations. Yet issues such as...
CorestemChemon Advances Toward ALS Stem Cell Commercialization with Regulatory Progress in Korea and NSF-Backed U.S. Expansion
SEOUL, South Korea, Dec. 18, 2025 /PRNewswire/ -- CorestemChemon (KOSDAQ: 166480) is entering a critical late-stage phase in the commercialization of its ALS stem cell therapy, Neuronata-R. The company attributes this momentum to advanced domestic...
Alphamab Oncology Announces IND Application for Innovative PD-L1/ VEGFR2 Bispecific ADC JSKN027 was Officially Accepted by CDE
SUZHOU, China, Dec. 18, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN027, an independently developed innovative bispecific antibody-drug conjugate (ADC) targeting...
The Second Silk Fashion Gala Opens at China National Silk Museum
HANGZHOU, China, Dec. 18, 2025 /PRNewswire/ -- On December 12, the second Silk Fashion Gala opened at the China National Silk Museum in Hangzhou, bringing together over 200 participants from the fashion, textile, and cultural sectors, including...